# FDA Inspection 1182191 - Octapharma Plasma Inc - October 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a8177acb-e8dd-4fee-83ee-56d20393991b
Source feed: FDA_Inspections

> FDA Inspection 1182191 for Octapharma Plasma Inc on October 20, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182191
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1182191 - 2022-10-20](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/87e54769-7095-4b29-9684-8d8e70acd807)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/340ea7a7-4e93-4e3e-a74e-d14cbaba2aed

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d